Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 470
Immune Disorders Drugs 198
Cardiovascular Drugs 156
Biopharmaceuticals 133
Infectious Diseases Drugs 128
Drug Discovery 122
Central Nervous System Drugs 107
Endocrine and Metabolic Disorders Drugs 104
Clinical Trials 101
Musculoskeletal Disorders Drugs 97
Pharmaceuticals 91
Leukemia Drugs 84
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 55
Brain Cancer Drugs 51
Skin Cancer Drugs 50
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Respiratory Drugs 39
Immunosuppressive Drugs 37
Gastrointestinal Drugs 35
Infusions and Injectables 32
Drug Delivery 32
Pharmaceutical Intermediates 31
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 28
Bladder Cancer Drugs 27
Analgesics 27
Drugs by Therapeutic Area 24
HIV/AIDS Drugs 23
Kidney Cancer Drugs 22
Antibiotics 22
Prostate Cancer Drugs 19
Colon Cancer Drugs 19
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Anti-Obesity Drugs 7
Cough and Cold Drugs 6
Company Reports 5
Anxiety Drugs 5
Pharmacoeconomics 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Vitamins and Dietary Supplements 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,434 Results (Page 67 of 122)
- Relevance
  Sort by

Fondaparinux - Global Strategic Business Report

 Report
October 2025
180 Pages
Global

From

€5222EUR$5,850USD£4,541GBP

Chronic Venous Occlusions Treatment - Global Strategic Business Report

 Report
October 2025
282 Pages
Global

From

€5222EUR$5,850USD£4,541GBP

Cardiovascular Drugs - Global Strategic Business Report

 Report
October 2025
413 Pages
Global

From

€5222EUR$5,850USD£4,541GBP

Acute Agitation And Aggression Treatment Market Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4463EUR$5,000USD£3,881GBP

Lung Transplant Rejection - Pipeline Insight, 2025

 Drug Pipelines
April 2025
40 Pages
Global

From

€893EUR$1,000USD£776GBP

€1116EUR$1,250USD£970GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cardiomyopathy Therapies - Global Strategic Business Report

 Report
October 2025
250 Pages
Global

From

€5222EUR$5,850USD£4,541GBP

Pediatric Clinical Trials - Global Strategic Business Report

 Report
October 2025
389 Pages
Global

From

€5222EUR$5,850USD£4,541GBP

Omics-based Clinical Trials - Global Strategic Business Report

 Report
October 2025
176 Pages
Global

From

€5222EUR$5,850USD£4,541GBP

T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€1071EUR$1,200USD£931GBP

€1339EUR$1,500USD£1,164GBP

Cell And Gene Therapy Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III), By Indication (Oncology, Cardiology, CNS, Musculoskeletal, Infectious Diseases), By Region, And Segment Forecasts, 2025 - 2033

 Report
July 2025
150 Pages
Global

From

€5312EUR$5,950USD£4,618GBP

Vasculitis Treatment - Global Strategic Business Report

 Report
October 2025
183 Pages
Global

From

€5222EUR$5,850USD£4,541GBP

Dyslipidemia Drugs - Global Strategic Business Report

 Report
October 2025
268 Pages
Global

From

€5222EUR$5,850USD£4,541GBP

Atherosclerosis Therapeutics - Global Strategic Business Report

 Report
October 2025
181 Pages
Global

From

€5222EUR$5,850USD£4,541GBP

Heart Failure Drugs - Global Strategic Business Report

 Report
October 2025
179 Pages
Global

From

€5222EUR$5,850USD£4,541GBP

Heparin - Global Strategic Business Report

 Report
October 2025
184 Pages
Global

From

€5222EUR$5,850USD£4,541GBP

Acute Heart Failure (AHF) Therapeutics - Global Strategic Business Report

 Report
June 2025
299 Pages
Global

From

€5222EUR$5,850USD£4,541GBP

Transplant Immunosuppressive Drug Market - Forecasts from 2023 to 2028

 Report
June 2023
113 Pages
Global

From

€3973EUR$4,450USD£3,454GBP

Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

 Report
December 2018
180 Pages
Global

From

€993EUR$1,112USD£863GBP

€1241EUR$1,390USD£1,079GBP

Anticoagulants Market Size, Share & Trends Analysis Report by Drug Category (Novel Oral Anticoagulants, Direct Thrombin Inhibitors, Heparin), Route of Administration, Application, Region, with Growth Forecasts, 2025-2030

 Report
April 2025
125 Pages
Global

From

€5312EUR$5,950USD£4,618GBP

Benign Prostatic Hyperplasia Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
97 Pages
Global

From

€3500EUR$4,200USD£3,150GBP

2,434 Results (Page 67 of 122)
- 1
- 65
- 66
- 67
- 68
- 69

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.